University of Oxford at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

University of Oxford takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on risk factors and brain change, from midlife alcohol intake and later amyloid burden to longitudinal MRI changes linked to Alzheimer's pathology.

Organization	CTAD 2026 Attendance
University of Oxford Oxford, UK
	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Midlife alcohol intake and later-life amyloid burden according to APOE ε4 status (P156) Prevention and early disease Poster Wed Nov 18 7:15am–5:30pm Macrostructural brain changes associated with baseline Alzheimer’s disease pathology: A longitudinal MRI study with CSF biomarkers from BIOCARD (P285) PET and MRI imaging · Blood and CSF biomarkers

Organization

CTAD 2026 Attendance

University of Oxford

Oxford, UK

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Midlife alcohol intake and later-life amyloid burden according to APOE ε4 status (P156)

Prevention and early disease

Poster

Wed Nov 18
7:15am–5:30pm

Macrostructural brain changes associated with baseline Alzheimer’s disease pathology: A longitudinal MRI study with CSF biomarkers from BIOCARD (P285)

PET and MRI imaging · Blood and CSF biomarkers

Instantly find 20 buyers from University of Oxford

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction